Paliperidone palmitate is not currently available as a generic in 2024. The brand-name drug, Invega Sustenna, and its extended-release injectable formulation, Invega Trinza, are still protected by patents. [1]
When can generic paliperidone palmitate be expected?
The patent expiration dates for paliperidone palmitate are varied, with some expiring as early as 2024 and others extending into the late 2020s or beyond. [1] DrugPatentWatch.com tracks these expirations, which dictate when generic versions may become available. [1]
What is paliperidone palmitate used for?
Paliperidone palmitate is an antipsychotic medication used to treat schizophrenia and schizoaffective disorder. It is administered as a long-acting intramuscular injection. [2]
How does paliperidone palmitate work?
Paliperidone palmitate is the active metabolite of risperidone. It works by blocking dopamine and serotonin receptors in the brain, which helps to manage symptoms of psychosis. [3]
What are the different formulations of paliperidone palmitate?
Paliperidone palmitate is available in several long-acting injectable formulations, including once-monthly (Invega Sustenna) and once-every-three-months (Invega Trinza). [2] A longer-acting formulation, Invega Hafyera, administered every six months, has also been approved. [4]
Are there any current legal challenges to paliperidone palmitate patents?
Patent challenges can occur, impacting the timeline for generic entry. Information on specific legal actions or patent litigation concerning paliperidone palmitate would be detailed on specialized patent tracking websites. [1]
What are the alternatives to paliperidone palmitate?
Alternative treatments for schizophrenia and schizoaffective disorder include other antipsychotic medications, both oral and injectable, which may have different mechanisms of action, side effect profiles, and dosing frequencies. [3]
What is the typical cost of paliperidone palmitate?
As paliperidone palmitate is not yet available generically, the cost is currently associated with the brand-name formulations. Generic versions, once available, are typically priced lower than their brand-name counterparts. [1]